Back to search
FDAFDA · Food and drugs·Recall number Z-0998-2020

Accu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System Catalog Number: 06908217001

Published February 12, 2020 · Recall initiated: December 11, 2019

Summary

FDA records medical device Class II recall Z-0998-2020, published February 12, 2020 and initiated December 11, 2019. Recalling firm: Roche Diabetes Care, Inc.; Status: Terminated; Reported quantity: 92,836 vials; Lot: Lot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diabetes Care, Inc.
Distributor
Nationwide: Foreign: Austalia, India
Lot
Lot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Accu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System Catalog Number: 06908217001 recalled?

Yes. FDA published recall Z-0998-2020 on February 12, 2020. Reported hazard: Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions

What should I do if I have this product?

Voluntary: Firm initiated · Letter